A prospective study of 39 mother-infant dyads exposed to SARS-CoV-2 during pregnancy suggested that cognitive skills in ...

CT scan of chest, abdomen, and pelvis shows high-disease burden, including multiple mediastinal and hilar nodes, deposits in ...

A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered ...

Global and genetic analyses link low physical activity to rising heart disease mortality, while higher activity levels appear ...

A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

Early intensive BP control significantly reduces cardiovascular risk in older patients compared with delayed initiation of treatment.

The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.

A structured data ownership model—rooted in ICH GCP principles, supported by MHRA and FDA interpretations, and documented in validated system specifications—will enable sponsors to maintain compliance ...

During a live event, Matthew Lunning, DO, interpreted long-term outcomes of the ZUMA-7 and TRANSFORM trials.

Obexelimab is a monoclonal antibody designed to bind both CD19 and FcγRIIb receptors and inhibit the activity of B-cells linked to autoimmune diseases.

Fractyl Health, Inc. ( ($GUTS) ) has shared an update. On January 5, 2026, Fractyl Health outlined a catalyst-heavy 2026 plan centered on ...